MedTrace Logo

Treatment for Achilles Tendinopathy

NCT00835939 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2009-02-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether sclerotherapy using a 25% dextrose and 1% lidocaine solution is an efficacious treatment for patients with chronic Achilles tendinopathy who have failed a home based, heavy load eccentric training program.

Conditions

  • Achilles Tendinopathy
  • Achilles Tendon Enthesopathy
  • Mid-Portion Achilles Tendinopathy
  • Insertional Achilles Tendinopathy
  • Non-Insertional Achilles Tendinopathy

Interventions

DRUG

25% Dextrose and 1% Lidocaine

Up to 3 injections provided to neovessels outside of the tendon

DRUG

Lidocaine

Up to 3 injections provided to neovessels outside of the tendon

PROCEDURE

sclerotherapy

Sponsors & Collaborators

  • Sport Science Association of Alberta (SSAA)

    collaborator UNKNOWN

  • University of Calgary

    lead OTHER

Principal Investigators

  • J Preston Wiley, MD, MPE · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2010-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00835939 on ClinicalTrials.gov